Detection of circulating tumor cells in sufferers with breast most cancers utilizing the conditionally reprogrammed cell tradition methodology and reverse transcription-PCR of hTERT and MAGE A1-6
The current research aimed to confirm the efficacy of the conditionally reprogrammed cell (CRC) tradition methodology for the detection of circulating tumor cells (CTCs) in breast most cancers. CTCs have been remoted from the peripheral blood of sufferers with breast most cancers, and tradition of the collected CTCs was carried out in response to the conditional reprogramming protocol.
- Whole RNA was extracted from cultured CTCs, and the hTERT and MAGE A1-6 genes have been amplified utilizing reverse transcription-PCR (RT-PCR). As well as, RNA extraction from one other blood pattern was carried out and the expression of the 2 genes was analyzed by RT-PCR solely.
- Following CRC tradition, grown CTCs have been noticed in 7 samples (23.3%). The CTC detection charges by RT-PCR for the hTERT and MAGE A1-6 genes in CTCs grown utilizing the CRC tradition methodology have been 26.7 and 10.0%, respectively.
- The optimistic expression charges for the hTERT and MAGE genes in CTCs assessed by RT-PCR solely have been 44.1 and 23.5%, respectively. When combining the optimistic expression charges of RT-PCR solely and CRC tradition for the hTERT and MAGE A1-6 genes, CTC detection charges elevated to 53.Three and 23.3%, respectively. Moreover, when combining the optimistic expression charges of the 2 genes by both methodology, the CTC detection price was the best worth noticed.
- In conclusion, the current research revealed the potential of CRC tradition within the detection of CTCs in breast most cancers. Moreover, a mixture of CRC tradition and RT-PCR for the hTERT and MAGE A1-6 genes is helpful in enhancing the detection price of CTCs within the blood.
GPR81 Antibody |
|||
| ABD2766 | Lifescience Market | 100 ug | EUR 525.6 |
GPR81 Antibody |
|||
| DF2766 | Affbiotech | 200ul | EUR 420 |
GPR81 Antibody |
|||
| DF2766-100ul | Affinity Biosciences | 100ul | EUR 168 |
|
Description: WB,IHC,ELISA(peptide) |
|||
GPR81 Antibody |
|||
| DF2766-200ul | Affinity Biosciences | 200ul | EUR 210 |
|
Description: WB,IHC,ELISA(peptide) |
|||
GPR81 Antibody |
|||
| E38PA2627 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
GPR81 Antibody |
|||
| MBS5315564-01mL | MyBiosource | 0.1mL | EUR 470 |
GPR81 Antibody |
|||
| MBS5315564-5x01mL | MyBiosource | 5x0.1mL | EUR 1955 |
GPR81 antibody |
|||
| MBS535508-005mg | MyBiosource | 0.05mg | EUR 1185 |
GPR81 antibody |
|||
| MBS535508-5x005mg | MyBiosource | 5x0.05mg | EUR 5180 |
GPR81 antibody |
|||
| MBS535613-005mg | MyBiosource | 0.05mg | EUR 1185 |
GPR81 antibody |
|||
| MBS535613-5x005mg | MyBiosource | 5x0.05mg | EUR 5180 |
GPR81 Antibody |
|||
| MBS9604280-01mL | MyBiosource | 0.1mL | EUR 260 |
GPR81 Antibody |
|||
| MBS9604280-02mL | MyBiosource | 0.2mL | EUR 305 |
GPR81 Antibody |
|||
| MBS9604280-5x02mL | MyBiosource | 5x0.2mL | EUR 1220 |
GPR81 Antibody |
|||
| MBS8581443-01mL | MyBiosource | 0.1mL | EUR 305 |
GPR81 Antibody |
|||
| MBS8581443-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
GPR81 Antibody |
|||
| MBS8581443-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
GPR81 Antibody |
|||
| MBS8581443-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
GPR81 Antibody |
|||
| MBS8581443-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
GPR81 Antibody |
|||
| MBS9233170-01mL | MyBiosource | 0.1mL | EUR 415 |
GPR81 Antibody |
|||
| MBS9233170-5x01mL | MyBiosource | 5x0.1mL | EUR 1841 |
GPR81 Antibody |
|||
| MBS9418336-005mL | MyBiosource | 0.05mL | EUR 245 |
GPR81 Antibody |
|||
| MBS9418336-01mL | MyBiosource | 0.1mL | EUR 305 |
GPR81 Antibody |
|||
| MBS9418336-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
GPR81 antibody |
|||
| 20R-GR037 | Fitzgerald Industries International | 50 ug | Ask for price |
GPR81 antibody |
|||
| 20R-GR038 | Fitzgerald Industries International | 50 ug | Ask for price |
GPR81 antibody |
|||
| 70R-50946 | Fitzgerald Industries International | 100 ul | Ask for price |
GPR81 polyclonal antibody |
|||
| BS60353 | Bioworld Biotech | 50ul | EUR 275 |
|
Description: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
|||
GPR81 Conjugated Antibody |
|||
| C44942 | SAB | 100ul | EUR 476.4 |
GPR81 Conjugated Antibody |
|||
| MBS9452894-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
GPR81 Conjugated Antibody |
|||
| MBS9452894-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
GPR81 Conjugated Antibody |
|||
| MBS9452894-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
GPR81 Conjugated Antibody |
|||
| MBS9452894-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
GPR81 Conjugated Antibody |
|||
| MBS9452894-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
Anti- G-Protein Receptor GPR81/FKSG80 Antibody |
|||
| GWB-7C6221 | GenWay Biotech | 0.05 mg | Ask for price |
Anti- G-Protein Receptor GPR81/FKSG80 Antibody |
|||
| GWB-17F64B | GenWay Biotech | 0.05 mg | Ask for price |
GPR81 Antibody (C-term) |
|||
| E45R16611G-1 | EnoGene | 100 ul | EUR 395 |
GPR81 Antibody (C-term) |
|||
| E45R16611G-4 | EnoGene | 50 ul | EUR 295 |
GPR81 Antibody (C-term) |
|||
| MBS9211314-008mL | MyBiosource | 0.08mL | EUR 210 |
GPR81 Antibody (C-term) |
|||
| MBS9211314-04mL | MyBiosource | 0.4mL | EUR 430 |
GPR81 Antibody (C-term) |
|||
| MBS9211314-5x04mL | MyBiosource | 5x0.4mL | EUR 1910 |
GPR81 Antibody - middle region |
|||
| MBS3221244-01mL | MyBiosource | 0.1mL | EUR 455 |
GPR81 Antibody - middle region |
|||
| MBS3221244-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
GPR81 Rabbit Polyclonal Antibody |
|||
| E10G33395 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
Polyclonal GPR81 Antibody (C-term) |
|||
| APR16611G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR81 (C-term). This antibody is tested and proven to work in the following applications: |
|||
GPR81 Antibody (C-term) Blocking Peptide |
|||
| MBS9221533-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Anti GPRC5D Pab |
|||
| 165602 | Antibody Research Corporation | 100 µg | Ask for price |
Polyclonal FKSG80 / GPR81 Antibody (C-Terminus) |
|||
| APR15995G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human FKSG80 / GPR81 (C-Terminus). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal FKSG80 / GPR81 Antibody (N-Terminus) |
|||
| APR15997G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human FKSG80 / GPR81 (N-Terminus). This antibody is tested and proven to work in the following applications: |
|||
ARP79587_P050-25UL - GPR81 Antibody - middle region |
|||
| ARP79587_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
ARP79587_P050 - GPR81 Antibody - middle region (ARP79587_P050) |
|||
| ARP79587_P050 | Aviva Systems Biology | 100ul | EUR 389 |
Polyclonal FKSG80 / GPR81 Antibody (Extracellular Domain) |
|||
| APR15996G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human FKSG80 / GPR81 (Extracellular Domain). This antibody is tested and proven to work in the following applications: |
|||
G Protein-Coupled Receptor 81 (GPR81) Antibody |
|||
| abx028676-400l | Abbexa | 400 µl | EUR 518.75 |
G Protein-Coupled Receptor 81 (GPR81) Antibody |
|||
| abx028676-400ul | Abbexa | 400 ul | EUR 627.6 |
G Protein-Coupled Receptor 81 (GPR81) Antibody |
|||
| abx028676-80l | Abbexa | 80 µl | EUR 281.25 |
G Protein-Coupled Receptor 81 (GPR81) Antibody |
|||
| 20-abx008192 | Abbexa |
|
|
G Protein-Coupled Receptor 81 (GPR81) Antibody |
|||
| abx430538-200l | Abbexa | 200 µl | EUR 387.5 |
G Protein-Coupled Receptor 81 (GPR81) Antibody |
|||
| abx430538-200ul | Abbexa | 200 ul | EUR 460.8 |
G Protein-Coupled Receptor 81 (GPR81) Antibody |
|||
| abx233610-100g | Abbexa | 100 µg | EUR 350 |
G Protein-Coupled Receptor 81 (GPR81) Antibody |
|||
| abx233610-100ug | Abbexa | 100 ug | EUR 661.2 |
G Protein-Coupled Receptor 81 (GPR81) Antibody |
|||
| 20-abx147554 | Abbexa |
|
|
G Protein-Coupled Receptor 81 (GPR81) Antibody |
|||
| abx147554-1096tests | Abbexa | 10 × 96 tests | Ask for price |
G Protein-Coupled Receptor 81 (GPR81) Antibody |
|||
| abx147554-596tests | Abbexa | 5 × 96 tests | EUR 387.5 |
G Protein-Coupled Receptor 81 (GPR81) Antibody |
|||
| abx147554-96tests | Abbexa | 96 tests | EUR 300 |
OAAB11632-400UL - GPR81 Antibody - C-terminal region |
|||
| OAAB11632-400UL | Aviva Systems Biology | 400ul | EUR 389 |
FKSG80 / GPR81 Rabbit Polyclonal (N-Terminus) Antibody |
|||
| TA316879 | Origene Technologies GmbH | 50 µg | Ask for price |
FKSG80 / GPR81 Rabbit Polyclonal (C-Terminus) Antibody |
|||
| TA316881 | Origene Technologies GmbH | 50 µg | Ask for price |
G Protein-Coupled Receptor GPR81/FKSG80 Rabbit anti-Human Polyclonal Antibody |
|||
| GWB-FD5E50 | GenWay Biotech | 0.05 mg | Ask for price |
G Protein-Coupled Receptor GPR81/FKSG80 Rabbit anti-Human Polyclonal Antibody |
|||
| GWB-520F4D | GenWay Biotech | 0.05 mg | Ask for price |
FKSG80 / GPR81 Rabbit Polyclonal (Extracellular Domain) Antibody |
|||
| TA316878 | Origene Technologies GmbH | 50 µg | Ask for price |
GPR81 Peptide |
|||
| 42-015P | ProSci | 0.1 mg | EUR 405.6 |
|
Description: (IN) GPR81 / FKSG80 Peptide |
|||
Anti-GPR81 Antibody |
|||
| MBS821939-003mL | MyBiosource | 0.03mL | EUR 185 |
Anti-GPR81 Antibody |
|||
| MBS821939-01mL | MyBiosource | 0.1mL | EUR 255 |
Anti-GPR81 Antibody |
|||
| MBS821939-02mL | MyBiosource | 0.2mL | EUR 335 |
Anti-GPR81 Antibody |
|||
| MBS821939-5x02mL | MyBiosource | 5x0.2mL | EUR 1420 |
Anti-GPR81 antibody |
|||
| PAab03610 | Lifescience Market | 100 ug | EUR 494.4 |
Anti Bovine Leptin Antibody |
|||
| 111002 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Stercobilin Antibody Pab |
|||
| 165755 | Antibody Research Corporation | 100 µg | Ask for price |
GPR81 agonist 1 |
|||
| HY-135982 | MedChemExpress | 10 mg | EUR 2110.42 |
|
Description: GPR81 agonist 1 is a potent and highly selective GPR81 agonist, with EC50s of 58 nM and 50 nM for human and mouse GPR81, respectively. GPR81 agonist 1 inhibits lipolysis in differentiated 3T3-L1 adipocytes. GPR81 agonist 1 suppresses lipolysis in mice without cutaneous flushing. GPR81 agonist 1 displays remarkable selectivity for GPR81 over GPR109a[1]. |
|||
GPR81 agonist 2 |
|||
| HY-148563 | MedChemExpress | Get quote | Ask for price |
|
Description: GPR81 agonist 2 (compound 1) is a potent GPR81 agonist with EC50 values of 0.023, 0.123 µM for hGPR81, hGPR109A, respectively[1]. |
|||
GPR81 agonist 1 |
|||
| T62656-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: GPR81 agonist 1 |
|||
GPR81 agonist 1 |
|||
| T62656-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: GPR81 agonist 1 |
|||
GPR81 agonist 1 |
|||
| T62656-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: GPR81 agonist 1 |
|||
GPR81 agonist 1 |
|||
| T62656-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: GPR81 agonist 1 |
|||
GPR81 agonist 1 |
|||
| T62656-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: GPR81 agonist 1 |
|||
Anti Plant Glycan Antibody [CCRC-M95] |
|||
| 401030 | Antibody Research Corporation | 100 µg | Ask for price |
GPR81 Blocking Peptide |
|||
| 20-abx063821 | Abbexa |
|
|
GPR81 Blocking Peptide |
|||
| DF2766-BP | Affbiotech | 1mg | EUR 234 |
GPR81 Blocking Peptide |
|||
| MBS823921-1mg | MyBiosource | 1mg | EUR 190 |
GPR81 Blocking Peptide |
|||
| MBS823921-5mg | MyBiosource | 5mg | EUR 345 |
GPR81 Blocking Peptide |
|||
| MBS823921-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
GPR81 Blocking Peptide |
|||
| MBS9622997-1mg | MyBiosource | 1mg | EUR 380 |
GPR81 Blocking Peptide |
|||
| MBS9622997-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
Gpr81 (untagged) - Mouse G protein-coupled receptor 81 (Gpr81), (10ug) |
|||
| MC213165 | Origene Technologies GmbH | 10 µg | Ask for price |
Rabbit anti-GPR81 Antibody |
|||
| DL91627A-100ul | DL Develop | 100 ul | EUR 299 |
|
Description: GPR104; GPR81; HCA1; Hydroxycarboxylic acid receptor 1; G-protein coupled receptor 104; G-protein coupled receptor 81 |
|||
Rabbit anti-GPR81 Antibody |
|||
| DL91627A-50ul | DL Develop | 50 ul | EUR 209.3 |
|
Description: GPR104; GPR81; HCA1; Hydroxycarboxylic acid receptor 1; G-protein coupled receptor 104; G-protein coupled receptor 81 |
|||
Anti-GPR81 / FKSG80 antibody |
|||
| STJ71944 | St John's Laboratory | 100 µg | EUR 430.8 |
Rabbit anti-GPR81 Antibody |
|||
| YLD3601-100ul | Shanghai YL Biotech | 100 ul | EUR 320 |
|
Description: Rabbit polyclonal antibody to GPR81 |
|||
Rabbit anti-GPR81 Antibody |
|||
| YLD3601-50ul | Shanghai YL Biotech | 50 ul | EUR 200 |
|
Description: Rabbit polyclonal antibody to GPR81 |
|||
GPR81 ELISA KIT|Human |
|||
| EF009971 | Lifescience Market | 96 Tests | EUR 826.8 |
Anti- GPR162 Antibody Antibody |
|||
| GWB-AAD3BE | GenWay Biotech | 0.05 ml | Ask for price |
Anti- GPR162 Antibody Antibody |
|||
| GWB-C5010A | GenWay Biotech | 0.05 ml | Ask for price |
Anti- GPR162 Antibody Antibody |
|||
| GWB-39B7E0 | GenWay Biotech | 0.05 ml | Ask for price |
Gpr81 (GFP-tagged) - Mouse G protein-coupled receptor 81 (Gpr81), (10ug) |
|||
| MG225816 | Origene Technologies GmbH | 10 µg | Ask for price |
Gpr81 (Myc-DDK-tagged) - Mouse G protein-coupled receptor 81 (Gpr81) |
|||
| MR225816 | Origene Technologies GmbH | 10 µg | Ask for price |
Anti Mouse E3 Ubiquitin-Protein Ligase MYCBP2 Antibody, Phr1 |
|||
| 164056 | Antibody Research Corporation | 100 µg | Ask for price |
Incidence, scientific course and threat issue for recurrent PCR positivity in discharged COVID-19 sufferers in Guangzhou, China: A potential cohort research
The phenomenon of COVID-19 sufferers examined optimistic for SARS-CoV-2 after discharge (redetectable as optimistic, RP) emerged globally. The information of incidence price and threat elements for RP occasion and the scientific options of RP sufferers might present suggestions for virus containment and circumstances administration for COVID-19.
We prospectively collected and analyzed the epidemiological, scientific and virological information from 285 grownup sufferers with COVID-19 and bought their particular scientific final result (getting PCR optimistic or not throughout post-discharge surveillance). By March 10, 27 (9.5%) discharged sufferers had examined optimistic for SARS-CoV-2 of their nasopharyngeal swab after a median length of seven·Zero days (IQR 5·0-8·0).
In comparison with first admission, RP sufferers typically had milder scientific signs, decrease viral load, shorter size of keep and improved pulmonary circumstances at readmission (p<0.05). Elder RP sufferers (≥ 60 years previous) have been extra prone to be symptomatic in comparison with youthful sufferers (7/8, 87.5% vs. 3/19, 18.8%, p = 0.001) at readmission.
Age, intercourse, epidemiological historical past, scientific signs and underlying illnesses have been related between RP and non-RP sufferers (p>0.05). A protracted length of viral shedding (>10 days) throughout the first hospitalization [adjusted odds ratio [aOR]: 5.82, 95% confidence interval [CI]: 2.50-13.57 for N gene; aOR: 9.64, 95% CI: 3.91-23.73 for ORF gene] and better Ct worth (ORF) within the third week of the primary hospitalization (aOR: 0.69; 95% CI: 0.50-0.95) have been related to RP occasions.
In conclusion, RP occasions occurred in practically 10% of COVID-19 sufferers shortly after the detrimental checks, weren’t related to worsening signs and unlikely mirror reinfection. Sufferers’ lack of effectivity in virus clearance was a threat issue for RP end result. It’s noteworthy that elder RP sufferers (≥ 60 years previous) have been extra vulnerable to scientific signs at readmission.
| AffiAB | https://www.AffiAB.com |
| AffiASSAY | https://www.AffiASSAY.com |
| AffiCHECK | https://www.AffiCHECK.com |
| AffiCLONE | https://www.AffiCLONE.com |
| AffiCLEAN | https://www.AffiCLEAN.com |
| AffiDETECT | https://www.AffiDETECT.com |
| AffiDYE | https://www.AffiDYE.com |
| AffiELISA Kits | https://www.AffiELISA.com Kits |
| AffiEXTRACT | https://www.AffiEXTRACT.com |
| AffiNEURO | https://www.AffiNEURO.com |
| AffiNGS | https://www.AffiNGS.com |
| AffiPCR | https://www.AffiPCR.com |
| AffiPREP | https://www.AffiPREP.com |
| AffiPURE | https://www.AffiPURE.com |
| AffiREC | https://www.AffiREC.com |
| AffiSHIELD | https://www.AffiSHIELD.com |
| AffiSTAIN | https://www.AffiSTAIN.com |
| AffiVET | https://www.AffiVET.com |
Ovine Paratuberculosis: Seroprevalence and comparability of fecal tradition and direct fecal PCR assay
Johne’s illness is persistent, incurable illness, brought on by Mycobacterium avium subsp. paratuberculosis (MAP). Most research in Egypt targeted on incidence of the illness in cattle however few research have been reported presence of antibodies towards MAP in sheep. The current research decided the seroprevalence price of MAP amongst sheep in 4 Governorates and assessed the related threat elements to MAP-infection.
- The seroprevalence price of MAP amongst sheep was non-significant various between totally different Governorates, it was ranged between 3.75%-12.3%. The outcomes revealed that the seroprevalence price of the illness was considerably elevated in diarrheic sheep (11 %, 95 %CI: 7.2-16.2) throughout spring (15 %, 95 %CI: 8.3-25) and summer time (8%, 95 %CI: 4.13-13.8) seasons.
- Opposite, the age of sheep and make contact with with different ruminants like cattle or goats had non-significant impact of spreading of MAP-infection amongst sheep. The detection of MAP in feces of sheep was carried out utilizing tradition and PCR to find out the effectivity of each checks.
- The kappa check revealed good settlement between each checks for detection of MAP. The obtained discovering confirms the presence of MAP amongst sheep in Egypt. So, the suitable management measures ought to be taken to scale back spreading of the illness amongst sheep and cut back its financial losses.
FX Blocking Peptide |
|||
| 20-abx161511 | Abbexa |
|
|
F5 Blocking Peptide |
|||
| DF8265-BP | Affbiotech | 1mg | EUR 234 |
Ob Blocking Peptide |
|||
| DF8583-BP | Affbiotech | 1mg | EUR 234 |
ST Blocking Peptide |
|||
| DF8616-BP | Affbiotech | 1mg | EUR 234 |
AR Blocking Peptide |
|||
| DF6783-BP | Affbiotech | 1mg | EUR 234 |
MB Blocking Peptide |
|||
| DF7358-BP | Affbiotech | 1mg | EUR 234 |
FH Blocking Peptide |
|||
| DF7460-BP | Affbiotech | 1mg | EUR 234 |
CP Blocking Peptide |
|||
| DF9369-BP | Affbiotech | 1mg | EUR 234 |
C7 Blocking Peptide |
|||
| DF9410-BP | Affbiotech | 1mg | EUR 234 |
C5 Blocking Peptide |
|||
| DF7719-BP | Affbiotech | 1mg | EUR 234 |
GC Blocking Peptide |
|||
| DF7840-BP | Affbiotech | 1mg | EUR 234 |
TG Blocking Peptide |
|||
| DF7885-BP | Affbiotech | 1mg | EUR 234 |
T Blocking Peptide |
|||
| BF0015-BP | Affbiotech | 1mg | EUR 234 |
E7 Blocking Peptide |
|||
| BF0311-BP | Affbiotech | 1mg | EUR 234 |
AR Blocking Peptide |
|||
| BF0418-BP | Affbiotech | 1mg | EUR 234 |
PR Blocking Peptide |
|||
| BF0581-BP | Affbiotech | 1mg | EUR 234 |
RB Blocking Peptide |
|||
| BF0614-BP | Affbiotech | 1mg | EUR 234 |
ER Blocking Peptide |
|||
| BF0674-BP | Affbiotech | 1mg | EUR 234 |
OR Blocking Peptide |
|||
| DF10250-BP | Affbiotech | 1mg | EUR 234 |
GK Blocking Peptide |
|||
| DF3151-BP | Affbiotech | 1mg | EUR 234 |
C6 Blocking Peptide |
|||
| DF3963-BP | Affbiotech | 1mg | EUR 234 |
C9 Blocking Peptide |
|||
| DF3964-BP | Affbiotech | 1mg | EUR 234 |
MB Blocking Peptide |
|||
| DF4194-BP | Affbiotech | 1mg | EUR 234 |
NT Blocking Peptide |
|||
| DF4245-BP | Affbiotech | 1mg | EUR 234 |
PC Blocking Peptide |
|||
| DF4364-BP | Affbiotech | 1mg | EUR 234 |
F3 Blocking Peptide |
|||
| DF6400-BP | Affbiotech | 1mg | EUR 234 |
HP Blocking Peptide |
|||
| DF6467-BP | Affbiotech | 1mg | EUR 234 |
F9 Blocking Peptide |
|||
| DF6474-BP | Affbiotech | 1mg | EUR 234 |
GW Blocking Peptide |
|||
| 20-abx162574 | Abbexa |
|
|
GK Blocking Peptide |
|||
| AF0829-BP | Affbiotech | 1mg | EUR 234 |
GR Blocking Peptide |
|||
| AF5004-BP | Affbiotech | 1mg | EUR 234 |
GR Blocking Peptide |
|||
| AF6066-BP | Affbiotech | 1mg | EUR 234 |
GR Blocking Peptide |
|||
| AF6067-BP | Affbiotech | 1mg | EUR 234 |
TK Blocking Peptide |
|||
| AF6068-BP | Affbiotech | 1mg | EUR 234 |
TK Blocking Peptide |
|||
| AF7678-BP | Affbiotech | 1mg | EUR 234 |
Rb Blocking Peptide |
|||
| AF7698-BP | Affbiotech | 1mg | EUR 234 |
IR Blocking Peptide |
|||
| AF6098-BP | Affbiotech | 1mg | EUR 234 |
IR Blocking Peptide |
|||
| AF6099-BP | Affbiotech | 1mg | EUR 234 |
Ub Blocking Peptide |
|||
| MBS8247910-1mg | MyBiosource | 1mg | EUR 190 |
Ub Blocking Peptide |
|||
| MBS8247910-5mg | MyBiosource | 5mg | EUR 345 |
Ub Blocking Peptide |
|||
| MBS8247910-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
Ub Blocking Peptide |
|||
| MBS823327-1mg | MyBiosource | 1mg | EUR 190 |
Ub Blocking Peptide |
|||
| MBS823327-5mg | MyBiosource | 5mg | EUR 345 |
Ub Blocking Peptide |
|||
| MBS823327-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
GW Blocking Peptide |
|||
| MBS8202921-1mg | MyBiosource | 1mg | EUR 190 |
GW Blocking Peptide |
|||
| MBS8202921-5mg | MyBiosource | 5mg | EUR 345 |
GW Blocking Peptide |
|||
| MBS8202921-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
FX Blocking Peptide |
|||
| MBS8212235-1mg | MyBiosource | 1mg | EUR 190 |
FX Blocking Peptide |
|||
| MBS8212235-5mg | MyBiosource | 5mg | EUR 345 |
FX Blocking Peptide |
|||
| MBS8212235-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
C5 Blocking Peptide |
|||
| MBS9627011-1mg | MyBiosource | 1mg | EUR 380 |
C5 Blocking Peptide |
|||
| MBS9627011-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
CP Blocking Peptide |
|||
| MBS9628390-1mg | MyBiosource | 1mg | EUR 380 |
CP Blocking Peptide |
|||
| MBS9628390-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
C7 Blocking Peptide |
|||
| MBS9628431-1mg | MyBiosource | 1mg | EUR 380 |
C7 Blocking Peptide |
|||
| MBS9628431-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
OR Blocking Peptide |
|||
| MBS9620585-1mg | MyBiosource | 1mg | EUR 380 |
OR Blocking Peptide |
|||
| MBS9620585-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
C3 Blocking Peptide |
|||
| MBS9621927-1mg | MyBiosource | 1mg | EUR 380 |
C3 Blocking Peptide |
|||
| MBS9621927-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
C6 Blocking Peptide |
|||
| MBS9624136-1mg | MyBiosource | 1mg | EUR 380 |
C6 Blocking Peptide |
|||
| MBS9624136-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
C9 Blocking Peptide |
|||
| MBS9624137-1mg | MyBiosource | 1mg | EUR 380 |
C9 Blocking Peptide |
|||
| MBS9624137-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
F3 Blocking Peptide |
|||
| MBS9625773-1mg | MyBiosource | 1mg | EUR 380 |
F3 Blocking Peptide |
|||
| MBS9625773-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
HP Blocking Peptide |
|||
| MBS9625839-1mg | MyBiosource | 1mg | EUR 380 |
HP Blocking Peptide |
|||
| MBS9625839-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
AR Blocking Peptide |
|||
| MBS9626155-1mg | MyBiosource | 1mg | EUR 380 |
AR Blocking Peptide |
|||
| MBS9626155-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
AR Blocking Peptide |
|||
| MBS9617301-1mg | MyBiosource | 1mg | EUR 380 |
AR Blocking Peptide |
|||
| MBS9617301-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
NT Blocking Peptide |
|||
| MBS9624416-1mg | MyBiosource | 1mg | EUR 380 |
NT Blocking Peptide |
|||
| MBS9624416-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
PC Blocking Peptide |
|||
| MBS9624535-1mg | MyBiosource | 1mg | EUR 380 |
PC Blocking Peptide |
|||
| MBS9624535-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
AR Blocking Peptide |
|||
| MBS9618029-1mg | MyBiosource | 1mg | EUR 380 |
AR Blocking Peptide |
|||
| MBS9618029-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
AR Blocking Peptide |
|||
| MBS9620081-1mg | MyBiosource | 1mg | EUR 380 |
AR Blocking Peptide |
|||
| MBS9620081-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
PR Blocking Peptide |
|||
| MBS9620193-1mg | MyBiosource | 1mg | EUR 380 |
PR Blocking Peptide |
|||
| MBS9620193-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
RB Blocking Peptide |
|||
| MBS9620221-1mg | MyBiosource | 1mg | EUR 380 |
RB Blocking Peptide |
|||
| MBS9620221-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
ER Blocking Peptide |
|||
| MBS9620262-1mg | MyBiosource | 1mg | EUR 380 |
ER Blocking Peptide |
|||
| MBS9620262-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
T Blocking Peptide |
|||
| MBS9619752-1mg | MyBiosource | 1mg | EUR 380 |
T Blocking Peptide |
|||
| MBS9619752-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
E7 Blocking Peptide |
|||
| MBS9619999-1mg | MyBiosource | 1mg | EUR 380 |
E7 Blocking Peptide |
|||
| MBS9619999-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
AR Blocking Peptide |
|||
| MBS9620031-1mg | MyBiosource | 1mg | EUR 380 |
AR Blocking Peptide |
|||
| MBS9620031-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
FH Blocking Peptide |
|||
| MBS9626808-1mg | MyBiosource | 1mg | EUR 380 |
FH Blocking Peptide |
|||
| MBS9626808-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
V5 Blocking Peptide |
|||
| MBS9230730-INQUIRE | MyBiosource | INQUIRE | Ask for price |
GW Blocking Peptide |
|||
| MBS8309588-1mg | MyBiosource | 1mg | EUR 190 |
GW Blocking Peptide |
|||
| MBS8309588-5mg | MyBiosource | 5mg | EUR 345 |
GW Blocking Peptide |
|||
| MBS8309588-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
Mouse Lipin-1 Control/blocking peptide control/blocking peptide #1 |
|||
| LPN11-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Mouse Lipin-2 Control/blocking peptide control/blocking peptide #1 |
|||
| LPN21-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Mouse Lipin-3 Control/blocking peptide control/blocking peptide #1 |
|||
| LPN31-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
PEPT1 Blocking Peptide |
|||
| 20-abx063272 | Abbexa |
|
|
PEPT1 Blocking Peptide |
|||
| MBS822938-1mg | MyBiosource | 1mg | EUR 190 |
PEPT1 Blocking Peptide |
|||
| MBS822938-5mg | MyBiosource | 5mg | EUR 345 |
PEPT1 Blocking Peptide |
|||
| MBS822938-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
C-Peptide Blocking Peptide |
|||
| 3277BP-50 | Biovision | each | EUR 183.6 |
MIF Blocking Peptide |
|||
| 5571BP-50 | Biovision | each | EUR 183.6 |
ECM Blocking Peptide |
|||
| 3843BP-50 | Biovision | each | EUR 183.6 |
Brk Blocking Peptide |
|||
| 3847BP-50 | Biovision | each | EUR 183.6 |
SCD Blocking Peptide |
|||
| 3875BP-50 | Biovision | each | EUR 183.6 |
Sp3 Blocking Peptide |
|||
| 3887BP-50 | Biovision | each | EUR 183.6 |
TP2 Blocking Peptide |
|||
| 3941BP-50 | Biovision | each | EUR 183.6 |
LPL Blocking Peptide |
|||
| 3947BP-50 | Biovision | each | EUR 183.6 |
PKG Blocking Peptide |
|||
| 3452BP-50 | Biovision | each | EUR 183.6 |
SGK Blocking Peptide |
|||
| 3459BP-50 | Biovision | each | EUR 183.6 |
Lck Blocking Peptide |
|||
| 3498BP-50 | Biovision | each | EUR 183.6 |
NSF Blocking Peptide |
|||
| 3541BP-50 | Biovision | each | EUR 183.6 |
PI9 Blocking Peptide |
|||
| 3544RBP-50 | Biovision | each | EUR 183.6 |
Tau Blocking Peptide |
|||
| 3549RBP-50 | Biovision | each | EUR 183.6 |
TTP Blocking Peptide |
|||
| 3551BP-50 | Biovision | each | EUR 183.6 |
LXR Blocking Peptide |
|||
| 3641BP-50 | Biovision | each | EUR 183.6 |
HDC Blocking Peptide |
|||
| 3691BP-50 | Biovision | each | EUR 183.6 |
JNK Blocking Peptide |
|||
| 3701BP-50 | Biovision | each | EUR 183.6 |
BIK Blocking Peptide |
|||
| 3703BP-50 | Biovision | each | EUR 183.6 |
BIF Blocking Peptide |
|||
| 3704BP-50 | Biovision | each | EUR 183.6 |
BMF Blocking Peptide |
|||
| 3334RBP-50 | Biovision | each | EUR 183.6 |
PKC Blocking Peptide |
|||
| 3450BP-50 | Biovision | each | EUR 183.6 |
AFX Blocking Peptide |
|||
| 3404BP-50 | Biovision | each | EUR 183.6 |
NIK Blocking Peptide |
|||
| 3193RBP-50 | Biovision | each | EUR 183.6 |
AIF Blocking Peptide |
|||
| 3202BP-50 | Biovision | each | EUR 183.6 |
DR6 Blocking Peptide |
|||
| 3216RBP-50 | Biovision | each | EUR 183.6 |
Akt Blocking Peptide |
|||
| 3247BP-50 | Biovision | each | EUR 183.6 |
Bid Blocking Peptide |
|||
| 3172BP-50 | Biovision | each | EUR 183.6 |
RIP Blocking Peptide |
|||
| 3279BP-50 | Biovision | each | EUR 183.6 |
ASC Blocking Peptide |
|||
| 3291BP-50 | Biovision | each | EUR 183.6 |
Bid Blocking Peptide |
|||
| 3272BP-50 | Biovision | each | EUR 183.6 |
FRK Blocking Peptide |
|||
| 20-abx062636 | Abbexa |
|
|
FYB Blocking Peptide |
|||
| 20-abx062642 | Abbexa |
|
|
ID1 Blocking Peptide |
|||
| 20-abx062766 | Abbexa |
|
|
ALS Blocking Peptide |
|||
| 20-abx062775 | Abbexa |
|
|
IL2 Blocking Peptide |
|||
| 20-abx062781 | Abbexa |
|
|
IL4 Blocking Peptide |
|||
| 20-abx062783 | Abbexa |
|
|
IL4 Blocking Peptide |
|||
| 20-abx062784 | Abbexa |
|
|
IL4 Blocking Peptide |
|||
| 20-abx062785 | Abbexa |
|
|
IL5 Blocking Peptide |
|||
| 20-abx062787 | Abbexa |
|
|
